Business
“This is a bit of a moonshot for J&J.” Chairman and CEO of Johnson & Johnson Alex Gorsky discusses its experimental vaccine for COVID-19 that will begin clinical trials by September, and could be available for emergency use authorization in early 2021. Former FDA Commissioner Dr. Scott Gottlieb says deaths in the U-S related to the virus would likely peak toward the end of April and suggests that life might start returning to normal after the middle of May.